Cargando…

Analysis of Intestinal Short-Chain Fatty Acid Metabolism Profile After Probiotics and GLP-1 Treatment for Type 2 Diabetes Mellitus

Type 2 diabetes accounts for about 90% of diabetes patients, and the incidence of diabetes is on the rise as people’s lifestyles change. Compared with GLP-1 treatment, probiotic treatment can directly regulate homeostasis of the host gut microbe, and thus homeostasis of its metabolites. Currently, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Min, Qiuxia, Wang, Yan, Jin, TaiCheng, Zhu, Lei, Wu, XianYan, Li, YiKun, Wang, YanJiao, Xu, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280620/ https://www.ncbi.nlm.nih.gov/pubmed/35846273 http://dx.doi.org/10.3389/fendo.2022.892127

Ejemplares similares

Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Zhu, Yuan, et al.
Publicado: (2021)

GLP-1 RAs and SGLT-2 Inhibitors for Insulin Resistance in Nonalcoholic Fatty Liver Disease: Systematic Review and Network Meta-Analysis
por: Yan, Hongle, et al.
Publicado: (2022)

Grifola frondosa may play an anti-obesity role by affecting intestinal microbiota to increase the production of short-chain fatty acids
por: Hu, Ruxiao
Publicado: (2023)

The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome
por: Markowiak-Kopeć, Paulina, et al.
Publicado: (2020)

Fecal short chain fatty acids modify therapeutic effects of sleeve gastrectomy
por: Shen, Chongrong, et al.
Publicado: (2023)

Characteristics of Gut Microbiome and Its Metabolites, Short-Chain Fatty Acids, in Children With Idiopathic Short Stature
por: Li, Lin, et al.
Publicado: (2022)

Contributions of Colonic Short-Chain Fatty Acid Receptors in Energy Homeostasis
por: Kuwahara, Atsukazu
Publicado: (2014)

Dietary Complex Probiotic Supplementation Changed the Composition of Intestinal Short-Chain Fatty Acids and Improved the Average Daily Gain of Growing Pigs
por: Wang, Juan, et al.
Publicado: (2023)

Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients
por: Han, Meifang, et al.
Publicado: (2021)

GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
por: Wang, Jing-Yue, et al.
Publicado: (2023)

Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis
por: Lisco, Giuseppe, et al.
Publicado: (2022)

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
por: Silva, Ygor Parladore, et al.
Publicado: (2020)

Gut microbiota short-chain fatty acids and their impact on the host thyroid function and diseases
por: Mendoza-León, María José, et al.
Publicado: (2023)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

[Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures
por: Mieczkowska, Aleksandra, et al.
Publicado: (2021)

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
por: Zhao, Xin, et al.
Publicado: (2021)

Impact of GLP-1 receptor agonist versus omega-3 fatty acids supplement on obesity-induced alterations of mitochondrial respiration
por: Jansen, Kirsten M., et al.
Publicado: (2023)

Circadian secretion rhythm of GLP-1 and its influencing factors
por: Liu, Chuanfeng, et al.
Publicado: (2022)

Short-Chain Fatty Acids Differentially Affect Intracellular Lipolysis in a Human White Adipocyte Model
por: Jocken, Johan W. E., et al.
Publicado: (2018)

Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota
por: Wang, Ying, et al.
Publicado: (2021)

The central GLP-1: implications for food and drug reward
por: Skibicka, Karolina P.
Publicado: (2013)

The Role of GLP-1 Signaling in Hypoglycemia due to Hyperinsulinism
por: Danowitz, Melinda, et al.
Publicado: (2022)

Emerging Role of Caveolin-1 in GLP-1 Action
por: Puddu, Alessandra, et al.
Publicado: (2021)

GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH
por: Li, Qiu-Xuan, et al.
Publicado: (2021)

Coordinated Modulation of Energy Metabolism and Inflammation by Branched-Chain Amino Acids and Fatty Acids
por: Ye, Zhenhong, et al.
Publicado: (2020)

Probiotics intervention in preventing conversion of impaired glucose tolerance to diabetes: The PPDP follow-on study
por: Yan, Qun, et al.
Publicado: (2023)

L-Cell Expression of Melanocortin-4-Receptor Is Marginal in Most of the Small Intestine in Mice and Humans and Direct Stimulation of Small Intestinal Melanocortin-4-Receptors in Mice and Rats Does Not Affect GLP-1 Secretion
por: Kuhre, Rune E., et al.
Publicado: (2021)

Therapeutic Role and Ligands of Medium- to Long-Chain Fatty Acid Receptors
por: Hara, Takafumi, et al.
Publicado: (2014)

Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
por: Yang, Jiaying, et al.
Publicado: (2023)

Probiotic and resveratrol normalize GLP-1 levels and oxidative stress in the intestine of diabetic rats
por: Pegah, Atefeh, et al.
Publicado: (2021)

Composition of the intestinal microbiota and its variations between the second and third trimesters in women with gestational diabetes mellitus and without gestational diabetes mellitus
por: Liu, Nana, et al.
Publicado: (2023)

Probiotics for the improvement of metabolic profiles in patients with metabolic-associated fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
por: Wang, Qiuhong, et al.
Publicado: (2022)

Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus
por: He, Qiongyao, et al.
Publicado: (2022)

Dynamic changes and early predictive value of branched-chain amino acids in gestational diabetes mellitus during pregnancy
por: Wang, Xiaoxin, et al.
Publicado: (2022)

GLP-1 based therapeutics: simultaneously combating T2DM and obesity
por: Heppner, Kristy M., et al.
Publicado: (2015)

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
por: Rowlands, Jordan, et al.
Publicado: (2018)

From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
por: Holst, Jens Juul
Publicado: (2019)

The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
por: Du, Haiyang, et al.
Publicado: (2022)

Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora
por: Liu, Jiayue, et al.
Publicado: (2022)

Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome
por: Lin, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hnap8aidab6d0t7l75uhpts6h5